Evidence map›Paper›PMID 40690910›Full record

ReviewActa cytologica2026

Integration of Digital Cytology in Quality Assurance Programs for Cytopathology.

Yosep Chong, Maria Jesús Fernández Aceñero, Zaibo Li, Andrey Bychkov

Abstract readReview
In one paragraph

Review in Acta cytologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yosep ChongDepartment of Hospital Pathology, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea, ychong@catholic.ac.kr.
Maria Jesús Fernández AceñeroPathology Department, Clinico San Carlos University Hospital, Madrid, Spain.
Zaibo LiDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Andrey BychkovDepartment of Pathology, Kameda Medical Center, Kamogawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

<p>Background: Quality assurance (QA) and quality control (QC) are fundamental to maintaining high standards in cytopathologic diagnostics. The recent adoption of digital cytology (DC) has led to transformative changes in cytopathology workflows, including primary diagnosis, telecytopathology-based consultations, and rapid on-site evaluations (ROSEs). These technological developments call for a conceptual shift and redefinition of QA and QC frameworks in the DC era. Summary: This review explores the evolving landscape of QA and QC in cytopathology, with a focus on the integration of DC into existing quality systems. We examine the role of DC as both a QC tool and a platform for implementing DC-specific QA/QC protocols. Practical applications discussed include leveraging DC for conventional QA/QC tasks, such as education and training of laboratory staff and cytopathologists, and facilitating digital proficiency testing through cloud-based platforms. Additionally, we review current international recommendations for the adoption of DC in cytopathology and propose strategies for the safe and efficient management of digital environments. Key Messages: (i) DC is reshaping the practice of cytopathology and requires updated QA/QC strategies. (ii) DC can enhance QA/QC activities through improved training, proficiency testing, and collaborative diagnostics. (iii) The development and implementation of DC-specific protocols are essential for ensuring accuracy and reliability in digital cytopathologic practice. </p>.

Indexed as

CytodiagnosisPathology, ClinicalQuality Assurance, Health CareHumansQuality ControlTelepathologyWorkflowDigital cytologyDigital proficiency testingQuality assuranceTelecytopathology

Identifiers

PMID40690910
PMCPMC12503692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.